ABL Bio Inc
KOSDAQ:298380
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sunyes Electronic Manufacturing Guangdong Holding Co Ltd
SZSE:002388
|
CN |
|
D
|
Devyser Diagnostics AB
STO:DVYSR
|
SE |
|
I
|
Inox Green Energy Services Ltd
NSE:INOXGREEN
|
IN |
|
Zhaoke Ophthalmology Ltd
HKEX:6622
|
CN |
|
Highwoods Properties Inc
NYSE:HIW
|
US |
|
C
|
Chengdu Bright Eye Hospital Co Ltd
SZSE:301239
|
CN |
|
E
|
Enel Chile SA
SGO:ENELCHILE
|
CL |
ABL Bio Inc
Common Stock
ABL Bio Inc
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Common Stock
₩27.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Common Stock
₩239.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
8%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Common Stock
₩11.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Common Stock
₩9.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Common Stock
₩26.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
14%
|
CAGR 10-Years
25%
|
|
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
Common Stock
₩5.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ABL Bio Inc
Glance View
ABL Bio, Inc. engages in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-12-19. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.
See Also
What is ABL Bio Inc's Common Stock?
Common Stock
27.6B
KRW
Based on the financial report for Dec 31, 2025, ABL Bio Inc's Common Stock amounts to 27.6B KRW.
What is ABL Bio Inc's Common Stock growth rate?
Common Stock CAGR 5Y
4%
Over the last year, the Common Stock growth was 2%. The average annual Common Stock growth rates for ABL Bio Inc have been 5% over the past three years , 4% over the past five years .
